You are subscribed to the Ophthalmology Times Issue Alert.

Ophthalmology Times Issue Alert

eNewsletter Subscribe

Print Subscribe

Digital Edition Subscribe

March 26, 2014

Web Version  |  Share with a colleague  |  View Digital Edition

Facebook Like   Twitter Tweet

CHECK OUT OUR MARCH 15TH ISSUE

Individualizing refractive management of peds lenses

Pediatric cataract surgery is now approached as a refractive procedure in which multiple factors are taken into account to determine the timing of IOL implantation and power selection.
» Read more

CXL-LASIK reinforces cornea stability

Performing collagen crosslinking as a concurrent primary LASIK procedure—show data from comparative studies of patients with hyperopia and myopia at risk for ectasia or regression postLASIK—increases postoperative refractive and keratometric stability.
» Read more

GLP-1 targeted therapy may help diabetes patients

The role of ophthalmologists will become increasingly more vital in the management of type 2 diabetes as the numbers of patients with the disease is projected to double by 2030. Exenatide may prove to be an important adjunct to current oral anti-diabetes drugs. » Read more

Flap creation evolves over technology

Data from analyses of large, retrospective case series show better safety and efficacy when LASIK is performed using a femtosecond laser for flap creation. » Read more

Keratoconus diagnosis: prompt CXL treatment vital

Children and adolescents with keratoconus may have rapid progression between the ages of 8 and 19 years and immediate treatment with corneal crosslinking may stop that progression.
» Read more

Techniques and tips for tackling cortex removal

Complete removal of lens substance is critical in pediatric cataract surgery. M. Edward Wilson, MD, offers helpful strategies.
» Read more

 

Downloads

Ophthalmology Times App - Download Ophthalmology Times Digital Edition - Download

You are subscribed to the Ophthalmology Times Issue Alert.

Related Articles

Study supports laser use for epithelial removal when performing CXL

FDA responds to Avedro NDA

Calculating IOL power for children

Drug slows diabetic retinopathy progression, but delays may limit effect

 
Powered by Modern Medicine Advanstar Medical Communications Group